Literature DB >> 839281

In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization.

D G Pavel, M Zimmer, V N Patterson.   

Abstract

A simple and rapid procedure for in vivo labeling of red blood cells (RBC) is presented. The labeling is done with two consecutive intravenous injections, first of "cold" stannous pyrophosphate (Sn-PYP) and then of 99mTc-pertechnetate. Experimentally, a lag time of 30 min between the two injections was found to result in a mean RBC labeling of greater than 95% during the first hour after pertechnetate injection. A total of 75 patients have been explored by scintillation camera imaging of brain, heart, great vessels, aortic bifurcation, testicles, and lower extremities using the technique outlined. High-quality images were obtained.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 839281

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  73 in total

1.  Regional observer performance variation in the evaluation of gated cardiac blood pool studies.

Authors:  S A Jackson; R Nickerson; R H Martin; S Iles; D Barnes
Journal:  Eur J Nucl Med       Date:  1992

2.  Two kinds of diverticular disease.

Authors:  P Ryan
Journal:  Ann R Coll Surg Engl       Date:  1991-03       Impact factor: 1.891

3.  A study of ventricular contraction sequence in complete right bundle branch block by phase analysis.

Authors:  T Takeda; H Toyama; K Iida; T Masuoka; R Ajisaka; K Kuga; M Satoh; S Sugahara; W Jin; N Ishikawa
Journal:  Ann Nucl Med       Date:  1991-03       Impact factor: 2.668

4.  Late arrhythmia in adults with the mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction?

Authors:  M A Gatzoulis; J Walters; P R McLaughlin; N Merchant; G D Webb; P Liu
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

5.  Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations.

Authors:  A S Hambye; R Vandermeiren; A Vervaet; J Vandevivere
Journal:  Eur J Nucl Med       Date:  1995-01

6.  Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.

Authors:  A G Dupont; P Vanderniepen; A M Bossuyt; M H Jonckheer; R O Six
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

7.  Left ventricular function during graded exercise in patients with coronary artery disease and in control subjects.

Authors:  L J Melendez; D E Manyari; A A Driedger; T D Cradduck; A C MacDonald
Journal:  Can Med Assoc J       Date:  1981-03-01       Impact factor: 8.262

8.  Magnetic resonance assessment of aortic and mitral regurgitation.

Authors:  S R Underwood; R H Klipstein; D N Firmin; K M Fox; P A Poole-Wilson; R S Rees; D B Longmore
Journal:  Br Heart J       Date:  1986-11

9.  Oral OPC-8212 for the treatment of congestive heart failure: hemodynamic improvement and increased exercise capacity.

Authors:  M Inoue; B H Kim; M Hori; Y Tsuneoka; N Matsubara; T Kamada; K Kodama; M Naka; S Nanto; Y Higashino
Journal:  Heart Vessels       Date:  1986       Impact factor: 2.037

10.  In vivo labelling of RBC with 99mTc for blood pool imaging using different stannous radiopharmaceuticals.

Authors:  H I Popescu; J Lessem; M Erjavec; G F Füger
Journal:  Eur J Nucl Med       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.